1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thyroiditis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Thyroiditis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chianéa, T; Delage, M; Denizot, Y; Labrousse, F; Mathonnet, M; Truffinet, V	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thyroiditis

Article	Year
Platelet-activating factor and human thyroid cancer. European journal of endocrinology, 2005, Volume: 153, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adenoma; Adolescent; Adult; Aged; Carcinoma, Papillary; Female; Fibroblast Growth Factor 2; Goiter; Humans; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroiditis; Vascular Endothelial Growth Factor A	2005

Article

Year

Platelet-activating factor and human thyroid cancer.

European journal of endocrinology, 2005, Volume: 153, Issue:1

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adenoma; Adolescent; Adult; Aged; Carcinoma, Papillary; Female; Fibroblast Growth Factor 2; Goiter; Humans; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroiditis; Vascular Endothelial Growth Factor A

2005